These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 7593131)
1. Immunohistochemical analysis of nm23 protein expression in malignant bone tumors. Oda Y; Walter H; Radig K; Röse I; Neumann W; Roessner A J Cancer Res Clin Oncol; 1995; 121(11):667-73. PubMed ID: 7593131 [TBL] [Abstract][Full Text] [Related]
2. [Association of nm23-H1 with orthopedic oncological conditions]. Ha L; Guo W; Feng C; Li H Zhonghua Wai Ke Za Zhi; 1998 Aug; 36(8):477-9. PubMed ID: 11825445 [TBL] [Abstract][Full Text] [Related]
3. Expression of nm23 protein in human osteosarcoma in relationship with early metastasis. Liao WM; Chiu KY; Li FB; Qiu JS; Han SY; Chow SP Orthopedics; 2000 Nov; 23(11):1175-8. PubMed ID: 11103961 [TBL] [Abstract][Full Text] [Related]
4. Comparison of histological changes and changes in nm23 and c-MET expression between primary and metastatic sites in osteosarcoma: a clinicopathologic and immunohistochemical study. Oda Y; Naka T; Takeshita M; Iwamoto Y; Tsuneyoshi M Hum Pathol; 2000 Jun; 31(6):709-16. PubMed ID: 10872665 [TBL] [Abstract][Full Text] [Related]
5. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas. Machado I; Navarro S; Picci P; Llombart-Bosch A Pathol Res Pract; 2016 Sep; 212(9):811-6. PubMed ID: 27465835 [TBL] [Abstract][Full Text] [Related]
6. EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing's Sarcoma and Chondrosarcoma. Giordano G; Merlini A; Ferrero G; Mesiano G; Fiorino E; Brusco S; Centomo ML; Leuci V; D'Ambrosio L; Aglietta M; Sangiolo D; Grignani G; Pignochino Y Cells; 2021 Oct; 10(11):. PubMed ID: 34831119 [TBL] [Abstract][Full Text] [Related]
7. Expression of bone morphogenetic proteins and receptors in sarcomas. Guo W; Gorlick R; Ladanyi M; Meyers PA; Huvos AG; Bertino JR; Healey JH Clin Orthop Relat Res; 1999 Aug; (365):175-83. PubMed ID: 10627702 [TBL] [Abstract][Full Text] [Related]
8. Expression of c-met proto-oncogene product (c-MET) in benign and malignant bone tumors. Naka T; Iwamoto Y; Shinohara N; Ushijima M; Chuman H; Tsuneyoshi M Mod Pathol; 1997 Aug; 10(8):832-8. PubMed ID: 9267827 [TBL] [Abstract][Full Text] [Related]
9. Detection of c-fos expression in benign and malignant musculoskeletal lesions. Weisstein JS; Majeska RJ; Klein MJ; Einhorn TA J Orthop Res; 2001 May; 19(3):339-45. PubMed ID: 11398843 [TBL] [Abstract][Full Text] [Related]
10. Ezrin immunohistochemical expression in chondrosarcomas, osteosarcomas and Ewing sarcoma family of tumors. Machado I; Navarro S; Giner F; Alberghini M; Bertoni F; Llombart-Bosch A Virchows Arch; 2010 Jul; 457(1):87-9. PubMed ID: 20552365 [No Abstract] [Full Text] [Related]
11. Expression of bone morphogenetic proteins in human osteosarcoma. Immunohistochemical detection with monoclonal antibody. Yoshikawa H; Rettig WJ; Takaoka K; Alderman E; Rup B; Rosen V; Wozney JM; Lane JM; Huvos AG; Garin-Chesa P Cancer; 1994 Jan; 73(1):85-91. PubMed ID: 7506120 [TBL] [Abstract][Full Text] [Related]
12. Is Surgical Resection of the Primary Site Associated with an Improved Overall Survival for Patients with Primary Malignant Bone Tumors Who Have Metastatic Disease at Presentation? Malik AT; Alexander JH; Mayerson JL; Khan SN; Scharschmidt TJ Clin Orthop Relat Res; 2020 Oct; 478(10):2284-2295. PubMed ID: 32667758 [TBL] [Abstract][Full Text] [Related]
13. nm23 protein expression and p53 immunoreactivity in cutaneous fibrohistiocytic tumors. Lee CS; Clarke RA; Tran KT; Kearsley JH; Chou ST Pathology; 1999 May; 31(2):123-6. PubMed ID: 10399167 [TBL] [Abstract][Full Text] [Related]
14. Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation. Kanoe H; Nakayama T; Murakami H; Hosaka T; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Sasaki MS; Toguchida J Anticancer Res; 1998; 18(4A):2317-21. PubMed ID: 9703873 [TBL] [Abstract][Full Text] [Related]
15. Small cell osteosarcoma of bone: an immunohistochemical study with differential diagnostic considerations. Devaney K; Vinh TN; Sweet DE Hum Pathol; 1993 Nov; 24(11):1211-25. PubMed ID: 7503935 [TBL] [Abstract][Full Text] [Related]
16. p53 expression and its relationship to DNA alterations in bone and soft tissue sarcomas. Wadayama B; Toguchida J; Yamaguchi T; Sasaki MS; Yamamuro T Br J Cancer; 1993 Dec; 68(6):1134-9. PubMed ID: 8260365 [TBL] [Abstract][Full Text] [Related]
17. Experimental therapies and clinical trials in bone sarcoma. Chugh R J Natl Compr Canc Netw; 2010 Jun; 8(6):715-25. PubMed ID: 20581301 [TBL] [Abstract][Full Text] [Related]
18. MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone. Dujardin F; Binh MB; Bouvier C; Gomez-Brouchet A; Larousserie F; Muret Ad; Louis-Brennetot C; Aurias A; Coindre JM; Guillou L; Pedeutour F; Duval H; Collin C; de Pinieux G Mod Pathol; 2011 May; 24(5):624-37. PubMed ID: 21336260 [TBL] [Abstract][Full Text] [Related]
19. Sarcomas of bone in childhood: pathologic aspects. Kissane JM; Askin FB; Nesbit ME; Vietti TJ; Burgert EO; Cangir A; Gehan EA; Perez CA; Pritchard DJ; Tefft M Natl Cancer Inst Monogr; 1981 Apr; (56):29-41. PubMed ID: 6272116 [TBL] [Abstract][Full Text] [Related]
20. Increased expression of nucleoside diphosphate kinase/nm23 and c-Ha-ras mRNA is associated with spontaneous lung metastasis in rat-transplantable osteosarcomas. Honoki K; Tsutsumi M; Miyauchi Y; Mii Y; Tsujiuchi T; Morishita T; Miura S; Aoki M; Kobayashi E; Tamai S Cancer Res; 1993 Oct; 53(20):5038-42. PubMed ID: 8402697 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]